Triple
T14504084
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ripuarian law |
E340218
|
entity |
| Predicate | region |
P40
|
FINISHED |
| Object | Lower Rhine |
E360139
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Lower Rhine | Statement: [Ripuarian law, region, Lower Rhine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Lower Rhine Context triple: [Ripuarian law, region, Lower Rhine]
-
A.
Lower Rhine
chosen
The Lower Rhine is the downstream section of the Rhine River flowing from roughly Bonn through Germany and the Netherlands to the North Sea, known for its dense population, industry, and historical river landscapes.
-
B.
Upper Rhine
The Upper Rhine is a major section of the Rhine River flowing along the borders of France, Germany, and Switzerland, known for its historic cities, vineyards, and role as a key European waterway.
-
C.
High Rhine
The High Rhine is a stretch of the Rhine River in Central Europe, flowing swiftly between Lake Constance and Basel and forming part of the border between Germany and Switzerland.
-
D.
Mittelrhein
Mittelrhein is a scenic section of Germany’s Middle Rhine Valley, renowned for its steep vineyards, medieval castles, and picturesque riverside towns.
-
E.
RHINE
RHINE is a pivotal phase III clinical trial evaluating faricimab for the treatment of diabetic macular edema.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d822d9c0408190b9a2b3643e58bb4d |
completed | April 9, 2026, 10:06 p.m. |
| NER | Named-entity recognition | batch_69de94e0f9048190a2d266cfa4f9dfb6 |
completed | April 14, 2026, 7:26 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ff13322c548190bac21db2bfa56ee9 |
completed | May 9, 2026, 10:57 a.m. |
Created at: April 10, 2026, 1:21 a.m.